Profile data is unavailable for this security.
About the company
Bactiguard Holding AB is a Sweden-based company engaged in the development of solutions for preventing of device-related healthcare associated infections (HAI). Its technology is based on the Bactiguard Infection Protection (BIP), a thin coating permanently bound to the surface of medical devices. It consists of the noble metals: gold, palladium and silver, which reduces the adhesion of bacteria to the coated surfaces. Its product portfolio includes: BIP Foley Catherer, made from medical grade latex, and BIP Foley Catheter - Silicone, used for drainage and irrigation of the bladder; BIP Endotracheal Tube, for general anesthesia, intensive care, and emergency medicine for airway management and mechanical ventilation; and BIP Central Venous Catherer, made of polyurethane and used to administer drugs and intravenous solutions, monitor pressure and blood sampling. The Company is also present in Portugal, via a distribution agreement with Socime Medical Ltd, and Zambia.
- Revenue in SEK (TTM)254.96m
- Net income in SEK-56.11m
- Incorporated2010
- Employees163.00
- LocationBactiguard Holding ABBiblioteksgatan 25STOCKHOLM 114 35SwedenSWE
- Phone+46 84405880
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mentice AB | 274.55m | -23.28m | 536.95m | 130.00 | -- | 3.87 | 172.32 | 1.96 | -0.9104 | -0.9104 | 10.71 | 5.42 | 0.9243 | 2.77 | 4.38 | 2,250,394.00 | -7.84 | -7.69 | -15.21 | -13.07 | 85.89 | 83.67 | -8.48 | -10.00 | 0.9251 | -- | 0.0285 | -- | 25.54 | 11.74 | 90.81 | -- | -10.83 | -- |
| Gentian Diagnostics ASA | 146.78m | 2.22m | 631.69m | 58.00 | 324.80 | 3.92 | 55.74 | 4.30 | 0.1262 | 0.1262 | 9.35 | 10.47 | 0.7792 | 1.69 | 8.40 | 2,533,190.00 | 1.18 | -10.76 | 1.33 | -11.86 | 51.69 | 41.46 | 1.51 | -26.99 | 5.01 | -- | 0.0394 | -- | 32.98 | 27.63 | 54.92 | -- | -4.92 | -- |
| Omda AS | 420.67m | -25.98m | 647.42m | 271.00 | -- | 10.24 | 22.78 | 1.54 | -1.27 | -1.27 | 20.92 | 3.03 | 0.5847 | 37.93 | 13.47 | 1,447,038.00 | -3.83 | -4.92 | -7.72 | -6.37 | 93.07 | 90.22 | -6.55 | -9.83 | 1.15 | 0.0681 | 0.8875 | -- | 12.30 | 19.83 | 179.30 | -- | -3.93 | -- |
| Senzime AB (publ) | 55.29m | -131.46m | 649.41m | 52.00 | -- | 2.41 | -- | 11.74 | -1.09 | -1.09 | 0.4595 | 2.38 | 0.1533 | 1.57 | 4.91 | -- | -36.44 | -35.69 | -39.12 | -38.00 | 33.27 | -20.59 | -237.75 | -558.68 | 2.62 | -- | 0.0739 | -- | 154.77 | 61.90 | -1.09 | -- | -3.69 | -- |
| ADDvise Group AB (publ) | 1.63bn | 114.40m | 752.08m | 643.00 | 20.22 | 3.05 | 3.57 | 0.4625 | 0.5935 | 0.5935 | 8.38 | 3.93 | 0.565 | 8.37 | 5.77 | 2,606,250.00 | 3.98 | 3.72 | 4.82 | 4.77 | 42.07 | 48.95 | 7.04 | 5.89 | 1.40 | 2.35 | 0.6969 | 0.9405 | 44.30 | 38.62 | 27.62 | -- | 30.35 | -- |
| OssDsign AB | 127.49m | -90.44m | 776.39m | 25.00 | -- | 3.62 | -- | 6.09 | -1.00 | -1.00 | 1.35 | 2.20 | 0.4033 | 1.32 | 5.96 | 2,656,063.00 | -28.61 | -37.92 | -31.51 | -43.56 | 88.64 | 68.10 | -70.94 | -203.06 | 5.44 | -20.45 | 0.01 | -- | 96.84 | 53.26 | -31.30 | -- | -56.16 | -- |
| Optomed Oyj | 157.57m | -69.40m | 901.75m | 113.00 | -- | 3.15 | -- | 5.72 | -0.3355 | -0.3355 | 0.763 | 1.26 | 0.4267 | 1.75 | 4.06 | 119,307.00 | -18.79 | -12.95 | -22.82 | -15.90 | 64.80 | 65.69 | -44.04 | -27.84 | 2.76 | -20.42 | 0.1313 | -- | 3.00 | 3.47 | 18.84 | -- | 7.26 | -- |
| C Rad AB | 497.02m | 53.43m | 913.09m | 94.00 | 17.53 | 3.10 | 14.59 | 1.84 | 1.58 | 1.58 | 14.72 | 8.96 | 1.23 | 5.04 | 2.72 | 5,712,816.00 | 13.25 | 5.09 | 19.16 | 7.02 | 46.30 | 43.12 | 10.81 | 4.86 | 2.32 | -- | 0.0049 | 0.00 | 40.92 | 17.44 | 375.05 | 10.89 | 33.69 | -- |
| Bactiguard Holding AB | 254.96m | -56.11m | 1.07bn | 163.00 | -- | 3.67 | -- | 4.19 | -1.60 | -1.60 | 7.28 | 9.37 | 0.3706 | 3.84 | 7.60 | 1,174,917.00 | -8.16 | -7.56 | -11.32 | -8.81 | 47.53 | 47.91 | -22.01 | -26.28 | 0.5898 | -2.72 | 0.4175 | -- | -11.96 | 6.46 | -161.71 | -- | 8.43 | -- |
| BioPorto A/S | 54.22m | -95.22m | 1.12bn | 36.00 | -- | 8.26 | -- | 20.62 | -0.163 | -0.163 | 0.0939 | 0.2014 | 0.3376 | 3.39 | 6.12 | 1,126,000.00 | -59.29 | -71.10 | -74.24 | -96.55 | 70.62 | 63.38 | -175.62 | -239.22 | 4.91 | -52.72 | 0.0507 | -- | 6.87 | 3.54 | 25.81 | -- | -51.56 | -- |
| Paxman AB (publ) | 238.86m | 28.64m | 1.20bn | 102.00 | 41.91 | 8.21 | 25.52 | 5.01 | 1.50 | 1.50 | 12.54 | 7.67 | 1.31 | 2.74 | 6.56 | 2,624,791.00 | 15.66 | -5.08 | 20.74 | -7.76 | 70.27 | 69.38 | 11.99 | -5.07 | 1.98 | 12.73 | 0.0838 | -- | 43.99 | 29.35 | 180.69 | -- | 6.26 | -- |
| Sedana Medical AB (publ) | 174.14m | -57.24m | 1.22bn | 78.00 | -- | 1.28 | -- | 6.99 | -0.5763 | -0.5763 | 1.75 | 9.56 | 0.1697 | 1.16 | 10.14 | 2,204,317.00 | -5.58 | -5.77 | -5.84 | -6.08 | 70.60 | 64.06 | -32.87 | -36.13 | 6.02 | -30.48 | 0.0076 | -- | 25.23 | 21.59 | 18.90 | -- | 42.12 | -- |
Data as of Nov 22 2024. Currency figures normalised to Bactiguard Holding AB's reporting currency: Swedish Krona SEK
36.86%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Nordea Investment Management ABas of 31 Dec 2023 | 3.47m | 11.18% |
| Fj�rde AP-fondenas of 31 Dec 2023 | 3.37m | 10.86% |
| Handelsbanken Fonder ABas of 31 Dec 2023 | 1.97m | 6.33% |
| AMF Fonder ABas of 31 Dec 2023 | 1.71m | 5.50% |
| Lancelot Asset Management ABas of 31 Dec 2023 | 490.00k | 1.58% |
| Storebrand Asset Management ASas of 30 Sep 2024 | 156.17k | 0.50% |
| FCG Fonder ABas of 31 Oct 2024 | 104.73k | 0.34% |
| SEB Investment Management ABas of 13 May 2024 | 90.50k | 0.29% |
| Skandia Investment Management ABas of 30 Sep 2024 | 65.21k | 0.21% |
| Deka Investment GmbHas of 31 Mar 2024 | 24.00k | 0.08% |
More ▼
Data from 30 Jun 2023 - 31 Oct 2024Source: FactSet Research Systems Inc.
